Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion

Goodall, M., Tosh, J., Alshreef, A.O. orcid.org/0000-0003-2737-1365 et al. (1 more author) (2016) Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion. Value in Health, 19 (7). A366. ISSN 1524-4733

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2016 Elsevier. This is an author produced version of a paper subsequently published in Value in Health. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Dates:
  • Published: 31 October 2016
  • Published (online): 31 October 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield) > Sheffield Centre for Health and Related Research
Depositing User: Symplectic Sheffield
Date Deposited: 09 Mar 2017 16:03
Last Modified: 03 Nov 2017 02:47
Published Version: https://doi.org/10.1016/j.jval.2016.09.116
Status: Published
Publisher: Elsevier
Refereed: Yes
Identification Number: https://doi.org/10.1016/j.jval.2016.09.116

Download

Filename: 111902.pdf

Licence: CC-BY-NC-ND 4.0

Share / Export

Statistics